Duly Health and Care Physicians Now Offering Access to Galleri® Multi-Cancer Early Detection Test

DOWN­ERS GROVE, Ill. – Duly Health and Care, through its Chicagoland med­ical group, DuPage Med­ical Group, LTD., is now offer­ing access to the Gal­leri® mul­ti-can­cer ear­ly detec­tion (MCED) test, a ground­break­ing tool designed to screen for a sig­nal shared by more than 50 types of can­cer — many of which cur­rent­ly have no rec­om­mend­ed screen­ing tests.

Find­ing can­cer ear­ly can pro­vide more treat­ment options and improve the poten­tial for bet­ter out­comes. While tra­di­tion­al screen­ings, such as colono­scopies, mam­mo­grams, and skin checks, remain essen­tial, they only cov­er a lim­it­ed num­ber of can­cers. Accord­ing to the Amer­i­can Can­cer Soci­ety, rough­ly three out of four can­cer-relat­ed deaths in the U.S. are from can­cers that have no rou­tine screen­ing options. The Gal­leri test helps close that gap by using a sim­ple blood draw to screen for mul­ti­ple can­cers at once.

“Ear­ly detec­tion can make all the dif­fer­ence in can­cer care,” said Michael Fitzger­ald, MD, a pri­ma­ry care physi­cian with Duly Health and Care. ​“The Gal­leri test gives us anoth­er tool to help patients take a proac­tive approach to their health. With just one blood draw, we can screen for many can­cers before there are symp­toms. This one test helps us catch poten­tial con­cerns ear­li­er than ever before.”

If a can­cer sig­nal is detect­ed, the Gal­leri test can also pre­dict where the sig­nal may have orig­i­nat­ed, help­ing guide next steps in diag­no­sis and treat­ment planning.

“We know the inci­dence of cer­tain can­cers is on the rise in the Unit­ed States, increas­ing the impor­tance of diag­nos­tics and pre­ven­tion,” said Bri­an Myre, MD, oncol­o­gist and direc­tor of the Bri­an Moran Can­cer Insti­tute at Duly Health and Care. ​“While we have made major advance­ments in can­cer treat­ments, we must also focus on improv­ing detec­tion and pre­ven­tion. The Gal­leri test has the poten­tial to play a mean­ing­ful role in this pursuit.”

The Gal­leri test is rec­om­mend­ed for adults with an ele­vat­ed risk for can­cer, such as those aged 50 and old­er. It is avail­able in addi­tion to reg­u­lar can­cer screen­ings advised by each patient’s pri­ma­ry care provider. 

With the addi­tion of this test, Duly Health and Care reaf­firms its mis­sion to pro­vide inno­v­a­tive, acces­si­ble, and patient-cen­tered care that empow­ers patients to take action toward health­i­er, longer lives.

The Gal­leri test is avail­able as a $749 cash-pay option for Duly patients or is cov­ered by TRI­CARE® health plans for eli­gi­ble patients ages 50 and up. Patients may be able to use pre­tax dol­lars in their flex­i­ble spend­ing account (FSA) or health sav­ings account (HSA) to pay for the Gal­leri test. Patients should check with their FSA/HSA admin­is­tra­tor or insur­ance provider to deter­mine eligibility. 

View all impor­tant safe­ty infor­ma­tion from Gal­leri: https://​www​.gal​leri​.com/​s​a​f​e​t​y​-​i​n​f​o​r​m​ation

###

About Duly Health and Care

The Duly Health and Care brand con­sists of some of the largest inde­pen­dent, mul­ti-spe­­cial­­ty, physi­­cian-direc­t­ed med­ical groups in the nation, with more than 1,000 pri­ma­ry care and spe­cial­ty care providers and over 6,000 team mem­bers across more than 150 loca­tions. The Duly Health and Care brand includes three med­ical groups — DuPage Med­ical Group Ltd., Quin­cy Med­ical Group, and The South Bend Clin­ic LLC. Duly is deeply com­mit­ted to car­ing for patients in tra­di­tion­al and val­ue-based care arrange­ments, ensur­ing a focus on qual­i­ty, effi­cien­cy, and enhanced patient expe­ri­ences through­out the Midwest.

For more infor­ma­tion, vis­it duly​healt­hand​care​.com.